Savior Lifetec Corporation announced that it is signed a sales contract with Shenzhen China Resources GOSUN Pharmaceuticals, authorizing the company to exclusively sell the company's ertapenem injection products in the mainland market. Effect on company finances and business: Accelerating the introduction of ertapenem into the Chinese mainland market will help increase the global market share of the company's products. Concrete purpose/objective: Through this cooperation project, the company will open a new milestone in the company's mainland market sales.